Xi Shi

2PUBLICATIONS
27CO-AUTHORS
Medical infection agents (incl. prions)Reaction engineering (excl. nuclear reactions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|May 22, 2020
Selective inhibition of glycogen synthase kinase 3α corrects pathophysiology in a mouse model of fragile X syndrome.

Patrick K McCamphill, Laura J Stoppel, Rebecca K Senter

|Sep 01, 2018
Engineered CRISPR-Cas9 nuclease with expanded targeting space.

Hiroshi Nishimasu, Xi Shi, Soh Ishiguro

Pageof 1